BR0008640A - Dispositivo de administração transdérmica - Google Patents

Dispositivo de administração transdérmica

Info

Publication number
BR0008640A
BR0008640A BR0008640-1A BR0008640A BR0008640A BR 0008640 A BR0008640 A BR 0008640A BR 0008640 A BR0008640 A BR 0008640A BR 0008640 A BR0008640 A BR 0008640A
Authority
BR
Brazil
Prior art keywords
nsaid
pharmaceutical composition
acid esters
fatty acid
transdermal administration
Prior art date
Application number
BR0008640-1A
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Alejandro Fabio Scasso
Roberto Juan Gabach
Original Assignee
Amarin Technologies S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Technologies S A filed Critical Amarin Technologies S A
Publication of BR0008640A publication Critical patent/BR0008640A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

"DISPOSITIVO DE ADMINISTRAçãO TRANSDéRMICA". Ainvenção pertence a dispositivos de administração transdérmica, emais particularmente, a dispositivos de administração transdérmicaque contêm: (a) composição farmacêutica para a administraçãosistêmica de NSAID; (b) camada suporte; e, (c) forro de liberação;em que a citada composição farmacêutica inclui pelo menos umcomponente que realça permeação subcutânea selecionada de: (i)álcoois graxos (C~ 4~-C~ 30~); (ii) ésteres (C~ 4~-C~ 30~) mono,di ou triglicerila de ácidos graxos; e, (iii) ésteres (C~ 4~C~ 30~) deácido graxo; e a matriz de adesivo acrílico sensível a pressãoformada através de copolímero com grupos funcionais polar emque o NSAID é incorporado.
BR0008640-1A 1999-03-01 2000-02-29 Dispositivo de administração transdérmica BR0008640A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AR9900866 1999-03-01
PCT/GB2000/000707 WO2000051575A1 (en) 1999-03-01 2000-02-29 Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix

Publications (1)

Publication Number Publication Date
BR0008640A true BR0008640A (pt) 2001-12-18

Family

ID=3461151

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008640-1A BR0008640A (pt) 1999-03-01 2000-02-29 Dispositivo de administração transdérmica

Country Status (8)

Country Link
EP (1) EP1158967B1 (pt)
AT (1) ATE237319T1 (pt)
AU (1) AU2816700A (pt)
BR (1) BR0008640A (pt)
CA (1) CA2366852A1 (pt)
ES (1) ES2197077T3 (pt)
MX (1) MXPA01008785A (pt)
WO (1) WO2000051575A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1061900E (pt) 1999-01-14 2005-04-29 Noven Pharma Composicoes e metodos para libertacao de uma droga
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
US20040127531A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Adhesive coated sheet for dermal delivery of a selective cyclooxygenase-2 inhibitor
US20040126415A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
GB0524958D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
WO2007077741A1 (ja) * 2005-12-28 2007-07-12 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収型製剤
JPWO2009031318A1 (ja) * 2007-09-05 2010-12-09 興和株式会社 鎮痛・抗炎症剤含有外用剤
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
RU2702898C2 (ru) 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
KR100212961B1 (ko) * 1992-12-31 1999-08-02 조민호 경피투여시스템
JPH08509222A (ja) * 1993-04-22 1996-10-01 ミネソタ マイニング アンド マニュファクチャリング カンパニー 経皮抗炎症性組成物
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac

Also Published As

Publication number Publication date
AU2816700A (en) 2000-09-21
EP1158967B1 (en) 2003-04-16
CA2366852A1 (en) 2000-09-08
ES2197077T3 (es) 2004-01-01
ATE237319T1 (de) 2003-05-15
WO2000051575A1 (en) 2000-09-08
EP1158967A1 (en) 2001-12-05
MXPA01008785A (es) 2003-07-14

Similar Documents

Publication Publication Date Title
BR0008640A (pt) Dispositivo de administração transdérmica
AR097045A2 (es) Sistema terapéutico transdérmico
KR960700060A (ko) 활성 성분으로서 갈린타민을 함유한 경피 치료 시스템(transdermal therapeutic system with galanthamine as active ingredient)
DK0697860T3 (da) Estradiolholdigt transdermalt terapeutisk system
DE69426988T2 (de) Transdermale abgabe vorrichtung
ES2147858T3 (es) Matriz para el suministro transdermico de farmacos.
FI972950A0 (fi) Estradiolipitoinen laastari
MXPA04001676A (es) Sistema terapeutico transdermico con fentanilo o sustancias relacionadas.
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
BR0010618A (pt) Sistema terapêutico transdermal (tts), que contém tolterodina
WO2007011764A3 (en) Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
EP2204181A3 (en) Protease inhibitors
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
DK1355636T3 (da) Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
NZ502351A (en) Transdermal therapeutical system for delivery of levonorgestrel
ES2177290T3 (es) Sistema de administracion transdermica con hormonas e inhibidores de cristalizacion.
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
WO2002024157A3 (en) Acryl adhesive useful in transdermal drug delivery systems
IT1317736B1 (it) Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.
DK0474647T3 (da) Fremgangsmåde og indretning til frigivelse af lægemidler til huden
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
NZ595549A (en) Transdermal therapeutic system containing nicotine
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
WO2001026637A3 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1925 DE 27/11/2007.